Internal Medicine, Hematology & Oncology · Los Angeles, CA
NPI
1568788545
Since 2010
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
1515 N Vermont Ave, 8th Floor - Hematology/Oncology
Los Angeles, CA, 90027
Phone (323) 783-5722
Groups this clinician bills Medicare through
Medicare paid, 2024
$8,795
815 services
Medicare patients, 2024
17
Average age 66
Drug cost, 2024
$6.0M
2,307 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Sameer K Kulkarni prescribed most often to Medicare patients was Abiraterone Acetate, with 481 prescriptions and refills. In total Sameer K Kulkarni wrote 2,307 Medicare prescriptions that cost $6.0M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-01-21.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Abiraterone Acetate Generic | 481 | 527 | 75 | $78K |
| Prednisone Generic | 248 | 509 | 73 | $2,283 |
| Dexamethasone Generic | 193 | 222 | 66 | $3,284 |
| Xtandi Enzalutamide | 149 | 149 | 22 | $1.8M |
| Nivestym Filgrastim-Aafi | 131 | 131 | 29 | $147K |
| Ondansetron Hcl Generic | 124 | 125 | 66 | $1,170 |
| Anastrozole Generic | 76 | 223 | 23 | $2,091 |
| Nubeqa Darolutamide | 60 | 60 | 11 | $671K |
| Xarelto Rivaroxaban | 54 | 54 | Under 11 | $27K |
| Imatinib Mesylate Generic | 50 | 53 | Under 11 | $2,824 |
| Granix Tbo-Filgrastim | 43 | 43 | 15 | $31K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 41 | 41 | Under 11 | $537 |
| Eliquis Apixaban | 32 | 33 | Under 11 | $22K |
| Lorazepam Generic | 32 | 32 | Under 11 | $369 |
| Creon Lipase/Protease/Amylase | 29 | 41 | Under 11 | $15K |
Brand drugs: 714 claims; generic drugs: 1,593 claims; opioid claims: 66.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Sameer K Kulkarni were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.